PSYCHEMEDICS CORPORATION: pre-tax income or loss from continuing operations

What this measure means

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Exact concept: us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2009-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• PSYCHEMEDICS CORPORATION: total assets
• PSYCHEMEDICS CORPORATION: total liabilities
• PSYCHEMEDICS CORPORATION: stockholders equity
• PSYCHEMEDICS CORPORATION: cash and cash equivalents
• PSYCHEMEDICS CORPORATION: net income or loss
• PSYCHEMEDICS CORPORATION: operating cash flow
• PSYCHEMEDICS CORPORATION: capital expenditure payments
• PSYCHEMEDICS CORPORATION: revenue
• PSYCHEMEDICS CORPORATION: financing cash flow
• PSYCHEMEDICS CORPORATION: investing cash flow
• PSYCHEMEDICS CORPORATION: retained earnings or deficit
• PSYCHEMEDICS CORPORATION: basic weighted-average shares
• PSYCHEMEDICS CORPORATION: diluted weighted-average shares
• PSYCHEMEDICS CORPORATION: basic earnings per share
• PSYCHEMEDICS CORPORATION: diluted earnings per share
• PSYCHEMEDICS CORPORATION: income tax expense or benefit
• PSYCHEMEDICS CORPORATION: net property, plant and equipment
• PSYCHEMEDICS CORPORATION: share-based compensation expense
• PSYCHEMEDICS CORPORATION: operating income or loss
• PSYCHEMEDICS CORPORATION: current assets
• PSYCHEMEDICS CORPORATION: interest expense
• PSYCHEMEDICS CORPORATION: current liabilities
• PSYCHEMEDICS CORPORATION: current accounts payable
• PSYCHEMEDICS CORPORATION: net current accounts receivable
• PSYCHEMEDICS CORPORATION: common-stock repurchase payments
• PSYCHEMEDICS CORPORATION: operating expenses
• PSYCHEMEDICS CORPORATION: gross profit
• PSYCHEMEDICS CORPORATION: research and development expense
• PSYCHEMEDICS CORPORATION: common shares outstanding
• PSYCHEMEDICS CORPORATION: accumulated other comprehensive income or loss
• PSYCHEMEDICS CORPORATION: operating lease right-of-use asset
• PSYCHEMEDICS CORPORATION: operating lease liability
• PSYCHEMEDICS CORPORATION: long-term debt
• PSYCHEMEDICS CORPORATION: gross property, plant and equipment
• PSYCHEMEDICS CORPORATION: accumulated depreciation on property, plant and equipment
• PSYCHEMEDICS CORPORATION: other noncurrent assets
• PSYCHEMEDICS CORPORATION: accrued current liabilities
• PSYCHEMEDICS CORPORATION: prepaid expenses and other current assets
• PSYCHEMEDICS CORPORATION: net deferred tax assets
• PSYCHEMEDICS CORPORATION: net deferred tax liabilities
• PSYCHEMEDICS CORPORATION: comprehensive income or loss
• PSYCHEMEDICS CORPORATION: general and administrative expense
• PSYCHEMEDICS CORPORATION: depreciation, depletion and amortization
• PSYCHEMEDICS CORPORATION: other nonoperating income or expense
• PSYCHEMEDICS CORPORATION: nonoperating income or expense
• PSYCHEMEDICS CORPORATION: current income tax expense or benefit
• PSYCHEMEDICS CORPORATION: deferred income tax expense or benefit
• PSYCHEMEDICS CORPORATION: interest paid, net
• PSYCHEMEDICS CORPORATION: proceeds from issuing common stock
• PSYCHEMEDICS CORPORATION: operating lease payments
• PSYCHEMEDICS CORPORATION: change in accounts receivable
• PSYCHEMEDICS CORPORATION: change in accounts payable

Inspect the source

Entity

PSYCHEMEDICS CORPORATION / CIK 0000806517

Captured

2026-09-21T17:17:03.097Z

SEC response SHA-256

86f20b52a099e76620fe6881a053ed61515c47925a0b1b6a4ed64f7b833f6a17

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000806517.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))